|1.||Gramignoli, Roberto: 1 article (01/2013)|
|2.||Strom, Stephen C: 1 article (01/2013)|
|3.||Huang, Min: 1 article (01/2013)|
|4.||Yin, Lianhua: 1 article (01/2013)|
|5.||Xu, Yali: 1 article (01/2013)|
|6.||Xu, Meishu: 1 article (01/2013)|
|7.||Guo, Fenghua: 1 article (01/2013)|
|8.||Wang, Hongbing: 1 article (01/2013)|
|9.||Ren, Songrong: 1 article (01/2013)|
|10.||Shi, Xiongjie: 1 article (01/2013)|
12/01/1986 - "Steroid alcohol sulfotransferase (SAS) has been isolated from the cytosol of a human breast carcinoma cell line, MCF-7. "
12/01/1986 - "Endocrine steroid sulfotransferases: steroid alcohol sulfotransferase from human breast carcinoma cell line MCF-7."
03/01/1995 - "The effects of dehydroepiandrosterone sulfate (DHAS), a typical hydroxysteroid sulfotransferase (HSTase) inhibitor, and of 3'-phosphoadenosine 5'-phosphate (PAP), a nonspecific sulfation inhibitor on N-nitrosobis(2-oxopropyl)-amine (BOP)-induced initiation were examined in a rapid production model for pancreatic carcinomas in hamsters in order to elucidate the involvement of sulfotransferase in the metabolic activation of beta-oxypropylnitrosamines. "
11/01/1992 - "The higher concentration of C19-5-ene-steroids in ER negative cellular fractions could be due to differences in their metabolism; ER negative tumors either lack, or possess very low levels of, hydroxysteroid sulfotransferase which catalyzes formation of sulfate esters of C19-5-ene-steroids previously observed to be major metabolites produced by ER positive cells. "
|3.||Liver Diseases (Liver Disease)
|4.||Hepatocellular Carcinoma (Hepatoma)
|4.||dehydroacetic acid (DHAS)